Clinical Trial

Clinical Study of PSMA-targeted CAR-T Cells in the Treatment of Castration-resistant Prostate Cancer

Recruiting Phase 1
View on ClinicalTrials.gov →
Record status
This record was last updated April 29, 2022 (before its estimated November 30, 2025 completion). Its status may not reflect the trial's current state.
Summary
This is an experimental study to evaluate the safety and effectiveness of PSMA-targeted CAR-T cells in the treatment of castration-resistant prostate cancer.
Trial Details
NCT Number NCT05354375
Lead Sponsor The Affiliated Hospital of Xuzhou Medical University
Collaborators: Xuzhou Medical University
Conditions Immunotherapy
Enrollment 20 participants
Start Date 2022-12-01
Primary Completion 2025-11-30 (estimated)
Study Completion 2026-11-30 (estimated)
Updated on ClinicalTrials.gov 2022-04-29